SEC Form 4 · accession 0001209191-19-006217
Dare Bioscience, Inc. · DARE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lisa Walters-Hoffert
Officer — Chief Financial Officer
Period of report
Jan 29, 2019
Accepted (ET)
Jan 31, 2019 · 5:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401914
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $0.759 | Jan 29, 2019 | A | 75,000 | A | — | Jan 29, 2029 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer.